Position in IONS
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$63,120,501
+$1,131,571 QoQ
Shares Held
840,598
+7.3% QoQ
Ownership
0.509%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 77.5193374240719.ToString("F0")%
Shared 0.ToString("F0")%
None 22.48066257592809.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Derivatives in IONS
reported options exposure · as of Sep 30, 2025CallValue
$2,943,900
CallShares
45,000
PutValue
$2,943,900
PutShares
45,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. IONS ranks #34 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in IONS
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,120,501 | 840,598 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $61,988,930 | 783,579 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,943,900 | 45,000 | Put | Defined | 2026-02-03 | |
| 2025-09-30 | $55,953,396 | 855,295 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $2,943,900 | 45,000 | Call | Defined | 2026-02-03 | |
| 2025-06-30 | $39,347,611 | 995,890 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,153,420 | 767,432 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $14,783,218 | 422,861 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,780,517 | 568,660 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $24,523,116 | 514,543 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,283,016 | 606,298 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $511,530 | 11,800 | Call | Defined | 2024-05-15 | |
| 2023-12-31 | $23,022,393 | 455,078 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $24,314,953 | 536,044 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $18,845,855 | 459,319 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,610,694 | 632,644 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $24,071,309 | 637,313 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $24,766,851 | 559,956 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,295,700 | 35,000 | Put | Defined | 2022-08-12 | |
| 2022-06-30 | $22,528,593 | 608,552 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,296,400 | 35,000 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $28,230,330 | 762,158 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $18,648,568 | 612,835 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $23,817,321 | 710,117 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,620,954 | 717,497 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,501,664 | 33,400 | Call | Defined | 2021-05-14 | |
| 2021-03-31 | $31,093,569 | 691,583 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,168,668 | 622,014 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $40,656,201 | 856,822 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $43,630,692 | 740,005 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $35,250,783 | 745,575 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||